New research signposts a new, less invasive approach to identify killer T lymphocytes in patients with gastrointestinal tumors with low mutational burden who are refractory to approved immune-based treatments.
from http://besthealthnews.com/2019/10/pioneering-cell-therapies-for-non-responders-to-current-immunotherapies/?utm_source=rss&utm_medium=rss&utm_campaign=pioneering-cell-therapies-for-non-responders-to-current-immunotherapies
from
https://healthnews010.tumblr.com/post/188400961293
No comments:
Post a Comment